Skip to content

Cardiovascular Manifestations of COVID-19

Cardiovascular Manifestations of COVID-19

Status
Withdrawn
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04701515
Enrollment
0
Registered
2021-01-08
Start date
2023-03-21
Completion date
2023-07-03
Last updated
2026-05-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19

Brief summary

Electronic medical record review of de-identified patients who tested positive for COVID-19 (using a PCR test) at Methodist Dallas Medical Center (MDMC) from June 2020 until the date of IRB approval. Data will be collected on de-identified patients that test positive for COVID-19 (using a PCR test) at MDMC from the date of IRB approval until December 2022. Disclaimer: Any cost associated with the procedures stated herein will be billed directly to you or to your insurance (as applicable)

Detailed description

Electronic medical record review of de-identified patients who tested positive for COVID-19 (using a PCR test) at Methodist Dallas Medical Center (MDMC) from June 2020 until the date of IRB approval. Data will be collected on de-identified patients that test positive for COVID-19 (using a PCR test) at MDMC from the date of IRB approval until December 2022. Variables include patient baseline characteristics, patient presentation, imaging and labs. Disclaimer: Any cost associated with the procedures stated herein will be billed directly to you or to your insurance (as applicable)

Interventions

OTHERChart review

Chart review

Sponsors

Methodist Health System
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* Hospitalized patient * Adult over 18 years * Positive COVID-19 PCR Test

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frameDescription
Heart failureMarch 2020 - June 2021Presence or absence
TamponadeMarch 2020 - June 2021Presence or absence
Pericardial EffusionMarch 2020 - June 2021Presence or absence
MyocarditisMarch 2020 - June 2021Presence or absence
PericarditisMarch 2020 - June 2021Presence or absence
ArrythmiasMarch 2020 - June 2021Presence or absence
Troponin IMarch 2020 - June 2021Level
N-terminal prohormone BNPMarch 2020 - June 2021Level

Secondary

MeasureTime frameDescription
StrokeMarch 2020 - June 2021Presence or absence
Myocardial infarctionMarch 2020 - June 2021Type
ShockMarch 2020 - June 2021Presence or absence
Deep venous thrombosisMarch 2020 - June 2021Presence or absence
Discharge dispositionMarch 2020 - June 2021Location
Primary diagnosisMarch 2020 - June 2021Diagnosis upon discharge
Rate of ICU admission/transferMarch 2020 - June 2021Rates
Total hospital length of stayMarch 2020 - June 2021Number of Days
ICU length of stayMarch 2020 - June 2021Number of Days
Percentage of patients in cohort that had EKG testing or EchocardiographyMarch 2020 - June 2021Percentage

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORManavjot Sidhu, MD

Methodist Health System

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 20, 2026